These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9925735)

  • 1. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family.
    Posner GH; Parker MH; Northrop J; Elias JS; Ploypradith P; Xie S; Shapiro TA
    J Med Chem; 1999 Jan; 42(2):300-4. PubMed ID: 9925735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity.
    Paik IH; Xie S; Shapiro TA; Labonte T; Narducci Sarjeant AA; Baege AC; Posner GH
    J Med Chem; 2006 May; 49(9):2731-4. PubMed ID: 16640333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
    O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
    Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A QSAR study of the antimalarial activity of some synthetic 1,2,4-trioxanes.
    Grigorov M; Weber J; Tronchet JM; Jefford CW; Milhous WK; Maric D
    J Chem Inf Comput Sci; 1997; 37(1):124-30. PubMed ID: 9025258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
    Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
    J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether.
    O'Neill PM; Searle NL; Kan KW; Storr RC; Maggs JL; Ward SA; Raynes K; Park BK
    J Med Chem; 1999 Dec; 42(26):5487-93. PubMed ID: 10639291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin.
    Posner GH; McGarvey DJ; Oh CH; Kumar N; Meshnick SR; Asawamahasadka W
    J Med Chem; 1995 Feb; 38(4):607-12. PubMed ID: 7861408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
    Singh C; Malik H; Puri SK
    J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1,2,4-trioxanes like artemisinin.
    Posner GH; Wang D; Cumming JN; Oh CH; French AN; Bodley AL; Shapiro TA
    J Med Chem; 1995 Jun; 38(13):2273-5. PubMed ID: 7608890
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1.
    Singh C; Chaudhary S; Kanchan R; Puri SK
    Org Lett; 2007 Oct; 9(21):4327-9. PubMed ID: 17877363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity.
    Posner GH; Oh CH; Wang D; Gerena L; Milhous WK; Meshnick SR; Asawamahasadka W
    J Med Chem; 1994 Apr; 37(9):1256-8. PubMed ID: 8176702
    [No Abstract]   [Full Text] [Related]  

  • 12. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation.
    Posner GH; Cumming JN; Woo SH; Ploypradith P; Xie S; Shapiro TA
    J Med Chem; 1998 Mar; 41(6):940-51. PubMed ID: 9526568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the study of artemisinin-related 1,2,4-trioxanes and ozonides (1,2,4-trioxolanes) as antimalarials].
    Yang ZS; Li Y
    Yao Xue Xue Bao; 2005 Dec; 40(12):1057-63. PubMed ID: 16496665
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationships of the antimalarial agent artemisinin. 5. Analogs of 10-deoxoartemisinin substituted at C-3 and C-9.
    Avery MA; Mehrotra S; Johnson TL; Bonk JD; Vroman JA; Miller R
    J Med Chem; 1996 Oct; 39(21):4149-55. PubMed ID: 8863791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New orally active spiro 1,2,4-trioxanes with high antimalarial potency.
    Singh C; Malik H; Puri SK
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4484-7. PubMed ID: 16105737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid-based 1,2,4-trioxanes: synthesis and antimalarial assessment.
    Singh C; Hassam M; Verma VP; Singh AS; Naikade NK; Puri SK; Maulik PR; Kant R
    J Med Chem; 2012 Dec; 55(23):10662-73. PubMed ID: 23163291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates.
    Avery MA; Alvim-Gaston M; Vroman JA; Wu B; Ager A; Peters W; Robinson BL; Charman W
    J Med Chem; 2002 Sep; 45(19):4321-35. PubMed ID: 12213073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
    Rudrapal M; Chetia D
    Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of the antimalarial agent artemisinin. 3. Total synthesis of (+)-13-carbaartemisinin and related tetra- and tricyclic structures.
    Avery MA; Fan P; Karle JM; Bonk JD; Miller R; Goins DK
    J Med Chem; 1996 Apr; 39(9):1885-97. PubMed ID: 8627612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme as trigger and target for trioxane-containing antimalarial drugs.
    Meunier B; Robert A
    Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.